Back to calendar
SAB Biotherapeutics, Inc. (SABS) Earnings
SABS reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026
Q3 2026
Est. EPS: $-0.27
Actual EPS: $-0.28
EPS surprise: 1.06%
Company overview
Market Cap$300.3M
PriceUSD 3.30
EPS (TTM)-1.66
52-week high5.15
52-week low2.44
SectorHealth Technology
IndustryBiotechnology
Employees86